BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26367490)

  • 1. The expression of genes involved in jejunal lipogenesis and lipoprotein synthesis is altered in morbidly obese subjects with insulin resistance.
    Gutierrez-Repiso C; Rodriguez-Pacheco F; Garcia-Arnes J; Valdes S; Gonzalo M; Soriguer F; Moreno-Ruiz FJ; Rodriguez-Cañete A; Gallego-Perales JL; Alcain-Martinez G; Vazquez-Pedreño L; Lopez-Enriquez S; Garcia-Serrano S; Garrido-Sanchez L; Garcia-Fuentes E
    Lab Invest; 2015 Dec; 95(12):1409-17. PubMed ID: 26367490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jejunal gluconeogenesis associated with insulin resistance level and its evolution after Roux-en-Y gastric bypass.
    Gutierrez-Repiso C; Garcia-Serrano S; Moreno-Ruiz FJ; Alcain-Martinez G; Rodriguez-Pacheco F; Garcia-Fuentes E
    Surg Obes Relat Dis; 2017 Apr; 13(4):623-630. PubMed ID: 28089435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jejunal wall triglyceride concentration of morbidly obese persons is lower in those with type 2 diabetes mellitus.
    Soriguer F; García-Serrano S; Garrido-Sánchez L; Gutierrez-Repiso C; Rojo-Martínez G; Garcia-Escobar E; García-Arnés J; Gallego-Perales JL; Delgado V; García-Fuentes E
    J Lipid Res; 2010 Dec; 51(12):3516-23. PubMed ID: 20855567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jejunal Insulin Signalling Is Increased in Morbidly Obese Subjects with High Insulin Resistance and Is Regulated by Insulin and Leptin.
    Gutierrez-Repiso C; Ho-Plagaro A; Santiago-Fernandez C; Garcia-Serrano S; Rodríguez-Pacheco F; Valdes S; Garrido-Sanchez L; Rodríguez-Díaz C; López-Gómez C; Moreno-Ruiz FJ; Alcain-Martinez G; Gautier-Stein A; Mithieux G; Garcia-Fuentes E
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia is associated with a lower expression of genes involved in lipogenesis in visceral adipose tissue.
    García-Fuentes E; Santiago-Fernández C; Gutiérrez-Repiso C; Mayas MD; Oliva-Olivera W; Coín-Aragüez L; Alcaide J; Ocaña-Wilhelmi L; Vendrell J; Tinahones FJ; Garrido-Sánchez L
    J Transl Med; 2015 Nov; 13():373. PubMed ID: 26619907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of sterol regulatory element binding protein-1c in livers of morbidly obese women is associated with altered suppressor of cytokine signaling-3 and signal transducer and activator of transcription-1 signaling.
    Elam MB; Yellaturu C; Howell GE; Deng X; Cowan GS; Kumar P; Park EA; Hiler ML; Wilcox HG; Hughes TA; Cook GA; Raghow R
    Metabolism; 2010 Apr; 59(4):587-98. PubMed ID: 19913854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosa-associated microbiota in the jejunum of patients with morbid obesity: alterations in states of insulin resistance and metformin treatment.
    Gutiérrez-Repiso C; Moreno-Indias I; Martín-Núñez GM; Ho-Plágaro A; Rodríguez-Cañete A; Gonzalo M; García-Fuentes E; Tinahones FJ
    Surg Obes Relat Dis; 2020 Oct; 16(10):1575-1585. PubMed ID: 32475753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects.
    Tinahones FJ; Garrido-Sanchez L; Miranda M; García-Almeida JM; Macias-Gonzalez M; Ceperuelo V; Gluckmann E; Rivas-Marin J; Vendrell J; García-Fuentes E
    Obes Surg; 2010 Nov; 20(11):1559-67. PubMed ID: 20512427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.
    Pettinelli P; Del Pozo T; Araya J; Rodrigo R; Araya AV; Smok G; Csendes A; Gutierrez L; Rojas J; Korn O; Maluenda F; Diaz JC; Rencoret G; Braghetto I; Castillo J; Poniachik J; Videla LA
    Biochim Biophys Acta; 2009 Nov; 1792(11):1080-6. PubMed ID: 19733654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
    Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
    Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis.
    Zhang YL; Hernandez-Ono A; Siri P; Weisberg S; Conlon D; Graham MJ; Crooke RM; Huang LS; Ginsberg HN
    J Biol Chem; 2006 Dec; 281(49):37603-15. PubMed ID: 16971390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo lipogenesis in adipose tissue is associated with course of morbid obesity after bariatric surgery.
    Garrido-Sánchez L; Vendrell J; Fernández-García D; Ceperuelo-Mallafré V; Chacón MR; Ocaña-Wilhelmi L; Alcaide J; Tinahones FJ; García-Fuentes E
    PLoS One; 2012; 7(2):e31280. PubMed ID: 22384010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyl-CoA synthetase short-chain family member 2 (ACSS2) is regulated by SREBP-1 and plays a role in fatty acid synthesis in caprine mammary epithelial cells.
    Xu H; Luo J; Ma G; Zhang X; Yao D; Li M; Loor JJ
    J Cell Physiol; 2018 Feb; 233(2):1005-1016. PubMed ID: 28407230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lower duodenal immune response is associated with an increase of insulin resistance in patients with morbid obesity.
    Ho-Plagaro A; Santiago-Fernandez C; García-Serrano S; Rodriguez C; Garrido-Sanchez L; Escamilla A; Gonzalo M; Montiel-Casado C; Alcaín-Martínez G; Garcia-Muñoz B; Ruiz-Santana N; Vázquez-Pedreño L; Garcia-Fuentes E
    Int J Obes (Lond); 2020 Feb; 44(2):340-352. PubMed ID: 31554917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity associated with type 2 diabetes mellitus is linked to decreased PC1/3 mRNA expression in the Jejunum.
    Rohden F; Costa CS; Hammes TO; Margis R; Padoin AV; Mottin CC; Guaragna RM
    Obes Surg; 2014 Dec; 24(12):2075-81. PubMed ID: 24831459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal-jejunal bypass surgery suppresses hepatic de novo lipogenesis and alleviates liver fat accumulation in a diabetic rat model.
    Han H; Hu C; Wang L; Zhang G; Liu S; Li F; Sun D; Hu S
    Obes Surg; 2014 Dec; 24(12):2152-60. PubMed ID: 24898720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid flux suppresses fatty acid synthesis in hamster intestine independently of SREBP-1 expression.
    Field FJ; Born E; Mathur SN
    J Lipid Res; 2003 Jun; 44(6):1199-208. PubMed ID: 12639972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose induces de novo lipogenesis in rat muscle satellite cells through a sterol-regulatory-element-binding-protein-1c-dependent pathway.
    Guillet-Deniau I; Pichard AL; Koné A; Esnous C; Nieruchalski M; Girard J; Prip-Buus C
    J Cell Sci; 2004 Apr; 117(Pt 10):1937-44. PubMed ID: 15039461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice.
    Yenilmez B; Kelly M; Zhang GF; Wetoska N; Ilkayeva OR; Min K; Rowland L; DiMarzio C; He W; Raymond N; Lifshitz L; Pan M; Han X; Xie J; Friedline RH; Kim JK; Gao G; Herman MA; Newgard CB; Czech MP
    J Biol Chem; 2022 Oct; 298(10):102401. PubMed ID: 35988648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.